HOME >> MEDICINE >> NEWS
Prostate cancer treatment increases risk of diabetes and heart disease

BOSTON -- A treatment mainstay for prostate cancer puts men at increased risk for diabetes and cardiovascular disease, according to a large observational study published in the Sept. 20 Journal of Clinical Oncology.

"Men with prostate cancer have high five-year survival rates, but they also have higher rates of non-cancer mortality than healthy men," says study author Nancy Keating, MD, MPH, assistant professor of health care policy and of medicine at Harvard Medical School. "This study shows that a common hormonal treatment for prostate cancer may put men at significant risk for other serious diseases. Patients and physicians need to be aware of the elevated risk as they make treatment decisions."

The principal systemic therapy for prostate cancer involves blocking testosterone production. This is done either by removal of the testes (bilateral orchiectomy), or more commonly, by regular injections of a gonadotropin-releasing hormone (GnRH) agonist drug. GnRH agonists are the main therapy for metastatic prostate cancer and may also improve survival for some men with locally-advanced cancers.

However, little is known about the efficacy of GnRH agonists in treating men with less-advanced local or regional prostate cancer, many of whom receive this therapy. Earlier studies have found GnRH agonists to be associated with obesity and insulin resistance, a precursor to diabetes.

"Our study found that men with local or regional prostate cancer receiving a GnRH agonist had a 44 percent higher risk of developing diabetes and a 16 percent higher risk of developing coronary heart disease than men who were not receiving hormone therapy," says Keating, who is also a physician at Brigham and Women's Hospital.

"Doctors should think twice about prescribing GnRH agonists in situations for which studies have not demonstrated improved survival until we better understand the risks of treatment," says co-author Matthew Smith, MD, PhD
'"/>

Contact: Leah Gourley
public_affairs@hms.harvard.edu
617-432-0442
Harvard Medical School
18-Sep-2006


Page: 1 2

Related medicine news :

1. Prostate cancer patients see high survival rates with seed implants
2. Prostate cancer research may be faster with PSA endpoints
3. Prostate treatment decisions based on perception more than fact
4. Prostate cancer test affected by demographic and lifestyle factors
5. Prostate cancer therapy - study suggests new molecular screening theory
6. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
7. Survival differences by race most apparent in advanced stages of breast cancer
8. Stomach cancer rate set to fall further 25 percent over next decade
9. MRI finds breast cancer before it becomes dangerous
10. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
11. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2018)... ... ... CapRock Health, the Brazos Valley’s only Independent and 100% locally owned Health ... Square Development in College Station, Texas on 11/16/2018. , “We are very ... and College Station area,” said Dr. Andy Wilson, CEO of CapRock Health. , CapRock ...
(Date:11/16/2018)... ... November 16, 2018 , ... Author ... Physician: How Science Transformed the Art of Medicine (GreenLeaf Press, 2018) was recently ... and medical. , Interweaving moving personal patient stories with a historical overview ...
(Date:11/16/2018)... ... 16, 2018 , ... It may surprise many people to learn that 25 ... provide care and support that reflect the important contributions made by these men and ... a pioneering campaign developed by National Hospice and Palliative Care Organization (NHPCO) in collaboration ...
(Date:11/16/2018)... , ... November 16, 2018 , ... ... licenses for the Grand Forks and Williston regions today. Dispensary Permits, a nationally ... be doing business as Strive Life in Grand Forks, North Dakota. , A ...
(Date:11/16/2018)... ... November 16, 2018 , ... Mount Sinai ... agreement with Taikang Healthcare in China to provide clinical and management knowledge transfer ... Nanjing, the capital of Jiangsu Province in east central China. , Mount Sinai ...
Breaking Medicine News(10 mins):
(Date:11/20/2018)... ... November 20, 2018 , ... PathSensors, ... announced today that it has been awarded a $7.2 million contract from the ... support to Department of Defense Facilities in the National Capital Region. The program ...
(Date:11/20/2018)... ... November 20, 2018 , ... Discovery Health Partners today announce the ... growth in the payment and revenue integrity space. New to the Discovery Board ... chairman, and CEO of ITM Software; and Chris Wenner, director at Carrick Capital Partners ...
(Date:11/17/2018)... LOS ANGELES (PRWEB) , ... November 16, 2018 , ... ... Congress gathering of hair transplant surgeons from all over the world. The event, ... Los Angeles hair transplant surgeon. , According to Dr. Mohebi, the founder of ...
Breaking Medicine Technology:
Cached News: